首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   745篇
  免费   18篇
  国内免费   4篇
耳鼻咽喉   4篇
儿科学   19篇
妇产科学   19篇
基础医学   102篇
口腔科学   11篇
临床医学   73篇
内科学   133篇
皮肤病学   16篇
神经病学   78篇
特种医学   24篇
外国民族医学   1篇
外科学   47篇
综合类   48篇
预防医学   49篇
眼科学   9篇
药学   88篇
  1篇
中国医学   28篇
肿瘤学   17篇
  2024年   2篇
  2023年   5篇
  2022年   10篇
  2021年   12篇
  2020年   15篇
  2019年   51篇
  2018年   60篇
  2017年   23篇
  2016年   16篇
  2015年   21篇
  2014年   49篇
  2013年   47篇
  2012年   39篇
  2011年   55篇
  2010年   41篇
  2009年   32篇
  2008年   38篇
  2007年   24篇
  2006年   15篇
  2005年   25篇
  2004年   20篇
  2003年   16篇
  2002年   14篇
  2001年   11篇
  2000年   8篇
  1999年   7篇
  1998年   3篇
  1997年   9篇
  1996年   2篇
  1995年   4篇
  1994年   6篇
  1993年   2篇
  1992年   4篇
  1991年   7篇
  1989年   2篇
  1987年   2篇
  1986年   2篇
  1985年   9篇
  1984年   15篇
  1983年   6篇
  1982年   3篇
  1981年   5篇
  1980年   6篇
  1979年   2篇
  1978年   6篇
  1977年   6篇
  1976年   2篇
  1973年   4篇
  1972年   2篇
  1968年   1篇
排序方式: 共有767条查询结果,搜索用时 31 毫秒
71.
用柱换HPLC法快速测定泽它洗剂中4-氯-3,5-二甲酚含量。以含量内标羟苯甲酸丙酯的甲醇,超声提取泽它洗剂,离心后取上清液直接进样。预柱为YWGC18(10um),分析柱为Shim-pack CLC-ODS(5um),流动相均为甲醇-水(70:30),检测波长280nm。平均加样回收率为99.84%,RSD=0.79%.  相似文献   
72.
73.
高效液相色谱法测定尿中2—硫代噻唑烷—4—羧酸浓度   总被引:2,自引:0,他引:2  
本文报道了用高效液相色谱(HPLC)法测定尿中2-硫代噻唑烷-4_羧酸(TTCA),选用Spherisorbs ODS 2色谱柱。TTCA浓度在0~120ng范围内为直线相关,γ-0.999。本法回收率为72.9%,最低检出量4ng。30名不接触CS_2者尿样中有23名可检出TTCA占76.7%,与15名接触CS_2 10mg/m~3以下的工人尿中TTOA测得值比较,经两样本等级和检验有统计显著性。初步得出本法的特异度为97%、敏感度为73%。  相似文献   
74.
A prostate biopsy is essential for prostate cancer diagnosis. However, infections are one of the biopsy-associated complications, and post-biopsy fever is estimated to occur in approximately 1% of all cases. It may thus be beneficial to perform a rectal swab culture before a transrectal prostate biopsy to confirm the presence of resistant bacteria and select preventive antibacterial agents according to the drug susceptibility results. This study aimed to determine whether there is a difference between the drug susceptibility of bacteria detected in the stool of patients who were scheduled to undergo prostate biopsy and the hospital-wide urine antibiogram. Patients suspected of having prostate cancer who underwent transrectal prostate biopsy via transrectal ultrasonography between August 1, 2016, and June 30, 2020, were included in this study. Stool samples were collected and cultured before biopsy. Overall, 99 patients underwent prostate biopsy, and of these, culture results were available for 81 patients (81.8%). Escherichia coli was detected in 74.0% (60 samples) of the stool culture samples, of which 4 samples were extended-spectrum β-lactamase-producing types. We found greater susceptibility of Escherichia coli to ampicillin, fluoroquinolones, sulfamethoxazole/trimethoprim, and cefixime in the stool culture antibiogram than in the hospital-wide urine antibiogram. We also found a significantly low incidence of ESBL-positive Escherichia coli in the stool culture antibiogram with p-values of 0.009, 0.007, and 0.03 compared to the hospital-wide urine antibiograms for 2017, 2018, and 2019, respectively. Stool culture of prostate cancer patients undergoing biopsy may provide useful information for selecting prophylactic antimicrobial agents.  相似文献   
75.
OBJECTIVES: This study evaluated the quantitative total betahCG assay on the Stratus CS point-of-care instrument at two medical centers. DESIGN AND METHODS: Analytical sensitivity, linearity, within-run and total imprecision, interferences, dilution recovery, method comparison (Dimension RxL), comparison of matched heparinized whole blood and plasma samples, and determination of the normal reference interval were studied. RESULTS: Analytical sensitivity was <0.5 IU/L. The assay's linear range was 0 to 1250 IU/L; the clinical reportable range was up to 50,000 IU/L. Within-run imprecision (CV) at both low (<20 IU/L) and elevated (760 IU/L) betahCG concentrations were <4%. Total imprecision for three QC levels and two pools were <4%. Method comparison showed Stratus CS betahCG = 0.98 +/- 0.01* Dimension RxL hCG -0.11 +/- 2.69 (n = 136; r = 0.996; Sy/x = 27.7). Matched heparinized whole blood/plasma sample-comparison showed: whole blood = 1.05*Plasma + 0.37 +/- 1.29 (n = 41; r = 1.000; Sy/x = 7.57). Mean dilution recovery was 99% (range: 95% to 103%). None of the 52 drugs tested, lipemia, icterus, hemolysis, LH, FSH, TSH, hGH or prolactin represented a significant interference with the assay. Reference intervals were <0.5 IU/L for males (n = 123) and <3.0 IU/L for nonpregnant females (n = 120). CONCLUSIONS: The Stratus CS betahCG test offers the advantage of quantitative measurement of total betahCG in whole blood at the point of care and is suitable for clinical use.  相似文献   
76.
目的研究更适宜急性呼吸窘迫综合征(ARDS)机械通气气管内吸痰的方式。方法采用静脉注射油酸制备动物ARDS模型;每只犬随机选择使用开放式气管内吸痰(OS)和密闭式气管内吸痰(CS)2种吸痰方式。于吸痰前后记录血流动力学等监测指标的数据。结果OS和CS后,犬平均肺动脉压(MPAP)与吸痰前比较均明显升高(P<0.05);OS后平均动脉压(MAP)显著升高(P<0.05)。结论OS、CS均可影响血流动力学的稳定。本研究提示,在护理工作中,对ARDS机械通气者应重视吸痰引起的继发性损害,加强吸痰前后血流动力学等监测。  相似文献   
77.
AIMS: To compare both short- and long-term stability and pacing parameters of CS leads. Long-term maintenance of coronary sinus (CS) pacing lead position has not yet been assessed by serial X-ray digital imaging. METHODS AND RESULTS: Using X-ray digital imaging in anteroposterior and left lateral views, we performed analysis of the CS lead position at the end of the implantation procedure, 48 h following implantation and after 12 months in 93 consecutive patients. Attain OTW leads, QuickSite leads and EasyTrak leads were implanted in 44, 12 and 37 cases, respectively. X-ray detectable late CS lead dislodgement was observed in 8 cases (8.6%) during 12-months follow-up. Dislodgment was once accompanied by loss of capture and need for repositioning. Another two major dislodgements occurred without any threshold change. Five (5.4%) minor dislocations occurred with either a decrease or an increase in pacing threshold. Left ventricular (LV) pacing threshold was changed by >or= 1 V after 12 months in 14 patients (15%) when compared to values 48 h after implantation. All but one case of >or= 1 V threshold change (either positive or negative) occurred without any radiological evidence of lead displacement. LV pacing threshold was significantly higher than RV pacing threshold at both baseline and during follow-up. Leads from all three manufacturers had comparable pacing thresholds 12 months following implantation. CONCLUSION: The position of CS leads may change during 1-year follow-up. However, it rarely required reoperation in the selected group of patients. Long-term pacing parameters between different manufacturers are comparable. Increase in pacing threshold is not a reliable marker of CS lead dislodgement.  相似文献   
78.
79.
Rheumatoid arthritis (RA) is a common autoimmune disease with a complex genetic background. The peptidyl arginine deiminase type IV (PADI4) gene has been associated with RA susceptibility in several populations. We addressed the relationship between three exonic PADI4 gene single nucleotide polymorphisms (SNPs) PADI4_89 (rs11203366), PADI4_90 (rs11203367) and PADI4_92 (rs874881) and related haplotypes with RA in a population from Southern México. This study included 200 RA patients and 200 control subjects. The SNPs were evaluated using the polymerase chain reaction-restriction fragment-length polymorphism (PCR-RFLP) technique, and antibodies to cyclic citrullinated peptides (anti-CCP) were measured by enzyme-linked immunosorbent assay (ELISA). In this population, the minor alleles of PADI4_891G, PADI4_901T and PADI4_921G gene polymorphisms were associated with RA susceptibility (OR = 1.34, p = 0.04; OR = 1.35, p = 0.03; OR = 1.34, p = 0.04; respectively). The GTG haplotype was also significantly associated with RA (OR = 2.27 95%CI = 1.18–4.41; p = 0.008), but did not show association with levels of anti-CCP antibodies and clinical parameters. In conclusion, our replication study in a Southern Mexican population suggests that PADI4 individual polymorphisms and the related susceptibility haplotype (GTG) are also genetic risk markers for RA.  相似文献   
80.
目的探讨CS风险系数表用于剖宫产后再次妊娠产妇分娩方式的选择及其判别中的价值。方法对某院97例剖宫产史足月分娩产妇采用CS风险系数表进行阴道分娩风险值预测,观察不同预测值下阴道试产的结局。结果 (1)分娩前胎儿性别全部按照男性计算,风险值﹤20%阴道试产成功率100.00%,20%~40%阴道试产成功率86.36%,﹥40%阴道试产成功率56.25%;分娩后根据实际新生儿性别矫正CS风险值,﹤20%阴道试产成功率100.00%,20%~40%阴道试产成功率89.74%,﹥40%阴道试产成功率50.00%;(2)试产失败组与试产成功组在胎儿窘迫、新生儿窒息发生率方面差异无统计学意义(P﹥0.05),出血量、住院天数、住院费用方面差异有统计学意义(P﹤0.05);(3)阴道试产失败产妇剖宫产原因胎儿窘迫占23.08%,滞产占69.23%,先兆子宫破裂占7.69%。结论利用CS风险系数表预测有剖宫产史再次妊娠产妇阴道试产风险,风险值﹤20%阴道试产基本均可成功,﹥40%阴道分娩成功率非常小,不建议考虑阴道试产。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号